Absence of evidence of Borna disease virus infection in Swedish patients with Chronic Fatigue Syndrome

被引:34
作者
Evengård, B [1 ]
Briese, T
Lindh, G
Lee, S
Lipkin, WI
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Immunol Microbiol Pathol & Infect Dis, Clin Infect Dis I73, S-14186 Huddinge, Sweden
[2] Univ Calif Irvine, Lab Study Emerging Dis, Irvine, CA 92697 USA
关键词
CFS; Borna disease virus; serum; PBMC; RT-PCR;
D O I
10.3109/13550289909045378
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Chronic Fatigue Syndrome (CFS) is characterized by debilitating fatigue, somatic symptoms and cognitive impairment. An infectious basis has been proposed; candidate agents include enteroviruses, herpesviruses, retroviruses and Borna disease virus (BDV), a novel neurotropic virus associated with neuropsychiatric disorders. Sera and peripheral blood mononuclear cells (PBMC) from Swedish CFS patients were assayed for evidence of infection using ELISA and Western immunoblot for detection of antibodies to BDV proteins N, P and gp18; and using nested reverse transcriptase polymerase chain reaction (RT-PCR) for detection of BDV N- and P-gene transcripts. No specific immunoreactivity to BDV proteins was found in sera from 169 patients or 62 controls. No BDV N- or P-gene transcripts were found through RT-PCR analysis of PBMC from 18 patients with severe CFS. These results do not support a role for BDV in pathogenesis of CFS.
引用
收藏
页码:495 / 499
页数:5
相关论文
共 25 条
[1]   Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome [J].
Bennett, AL ;
Chao, CC ;
Hu, SX ;
Buchwald, D ;
Fagioli, LR ;
Schur, PH ;
Peterson, PK ;
Komaroff, AL .
JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (02) :160-166
[2]   NO SEROLOGIC EVIDENCE OF BORNA DISEASE VIRUS IN PATIENTS WITH CHRONIC FATIGUE SYNDROME [J].
BODE, L ;
KOMAROFF, AL ;
LUDWIG, H .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (06) :1049-1049
[3]   BORNA-DISEASE VIRUS GENOME TRANSCRIBED AND EXPRESSED IN PSYCHIATRIC-PATIENTS [J].
BODE, L ;
ZIMMERMANN, W ;
FERSZT, R ;
STEINBACH, F ;
LUDWIG, H .
NATURE MEDICINE, 1995, 1 (03) :232-236
[4]   GENOMIC ORGANIZATION OF BORNA-DISEASE VIRUS [J].
BRIESE, T ;
SCHNEEMANN, A ;
LEWIS, AJ ;
PARK, YS ;
KIM, S ;
LUDWIG, H ;
LIPKIN, WI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4362-4366
[5]   ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR DETECTING ANTIBODIES TO BORNA-DISEASE VIRUS-SPECIFIC PROTEINS [J].
BRIESE, T ;
HATALSKI, CG ;
KLICHE, S ;
PARK, YS ;
LIPKIN, WI .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (02) :348-351
[6]  
Buchwald D, 1996, J MED VIROL, V50, P25, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt
[7]  
25::AID-JMV6&gt
[8]  
3.0.CO
[9]  
2-V
[10]   Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome [J].
Cannon, JG ;
Angel, JB ;
Abad, LW ;
Vannier, E ;
Mileno, MD ;
Fagioli, L ;
Wolff, SM ;
Komaroff, AL .
JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) :253-261